Key result
DeltaACT-LR detected excessive anticoagulation with an AUC of 0.87, but poor correlation between ACT-LR and APTT does not support its routine use.
Why the study?
Does the Hemochron Jr II Signature ACT-LR test accurately detect excessive anticoagulation compared to APTT in patients post-vascular surgery?
Observational (n=103)
Does the Hemochron Jr II Signature ACT-LR test accurately detect excessive anticoagulation compared to APTT in patients post-vascular surgery?
The Hemochron Jr II Signature ACT-LR test shows poor correlation with APTT, not supporting its routine use for monitoring low-dose heparin in vascular surgery.
Answers are grounded in this paper and cite their sources.
Caution against ACT-LR for low-dose heparin monitoring post-vascular surgery; leaves open whether refined thresholds improve APTT correlation in prospective cohorts.
The purpose of this study was to validate a device designed to measure activated clotting time in low-range heparin plasma concentrations (ACT-LR) prospectively during the post-operative period of vascular surgery. Measurement of ACT-LR and activated partial thromboplastin time (APTT) were performed before heparinisation (T0) and at the end of surgery (T1). ACT-LR(T1) and DeltaACT-LR (defined as ACT-LR(T1) - ACT-LR(T0)) were evaluated as diagnostic tests for excessive anticoagulation, defined by APTT more than twice the laboratory's normal, by Bland-Altman method and receiver operating characteristic (ROC) curves. In 103 patients, mean (SD) ACT-LR was 137 (33) s at T0 and 176 (39) s at T1. Bland-Altman graph did not show a good agreement between APTT and ACT-LR. Areas under ROC curves were 0.82 (95% CI: 0.75-0.89) and 0.87 (95% CI: 0.80-0.93) for ACT-LR(T1) and DeltaACT-LR, respectively. Using a threshold of 32 s for DeltaACT-LR, test sensitivity was 87% (95% CI: 81-93%), specificity was 85% (95% CI: 78-92%), positive predictive value was 90% (95% CI: 84-96%) and negative predictive value was 81% (95% CI: 73-86%). While DeltaACT-LR may have some potential in evaluating excessive anticoagulation in vascular surgery, the poor correlation between ACT-LR and APTT does not support its routine use.
No takes yet. Share an insight, caveat, or question.
Racioppi et al. (2009) conducted an observational in Vascular surgery requiring low dose heparin therapy (n=103). ACT-LR (Hemochron Jr II Signature) vs. APTT was evaluated on Excessive anticoagulation (APTT more than twice normal) (AUC 0.87, 95% CI 0.80-0.93). DeltaACT-LR detected excessive anticoagulation with an AUC of 0.87, but poor correlation between ACT-LR and APTT does not support its routine use.
Synapse has enriched 10 related papers. Consider them for comparative context: